Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | No |
| Zepbound (weight loss) | Limited |
| Ozempic or Mounjaro (type 2 diabetes) | Yes |
If California Medicaid says no, two cash programs to check.
No insurance needed.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
- Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Cheapest GLP-1 without insurance compares the three cash routes, and cheapest GLP-1 in California prices each drug that ships there.
A clinical trial costs nothing, and nobody checks your income.
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs California Medicaid has agreed to pay for. Prior authorization means your doctor asks the plan to approve the drug before the pharmacy fills it. Nearly every state covers the diabetes path that way.
| Criterion | Value |
|---|---|
| How hard the approval is | Hard |
| BMI threshold (weight-loss path) | The state does not publish one. Ask your plan. |
| Comorbidity required | No |
| Last PDL update reviewed | January 1, 2026 |
If the plan denies it, the appeal letter templates cover the reasons plans give and what to send back.
What Medi-Cal paid for GLP-1s
Medi-Cal reported 850,889 GLP-1 prescriptions to CMS in 2025's last quarter and paid pharmacies $946 million.
Counts Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Rybelsus, in fee-for-service and managed care, before rebates. CMS blanks its smallest rows, so the real figures are higher. Source: CMS State Drug Utilization Data.
What this means in practice
Adults lost weight-loss coverage on January 1, 2026: Medi-Cal Rx ended Wegovy, Zepbound and Saxenda for weight loss only, and prior approvals expired December 31, 2025. Coverage continues for members under 21 (EPSDT) and for cardiovascular, diabetes and MASH (a fatty liver disease) uses with prior authorization.
Managed-care organizations in California
California Medicaid pays private health plans, called managed-care organizations or MCOs, to run its coverage. The state contracts with 25, and these are the 5 largest. An MCO has to cover at least what the state list covers and can add rules of its own. Check your own plan's current rules before you send anything in.
- Anthem Blue Cross Medi-Cal
- L.A. Care Health Plan
- Molina Healthcare of California
- Health Net Community Solutions
- Kaiser Permanente Medi-Cal
Cash-pay alternatives if Medicaid does not cover you
Medi-Cal Rx dropped the weight-loss indication, so there is no BMI that qualifies. Three routes still go through with the diagnosis on file: cardiovascular disease, type 2 diabetes and MASH, a fatty liver disease.
If you end up paying cash, the GLP-1 cost guide has what each cash route costs, from the compounded floor to the manufacturer-direct brand prices. Federal law bars manufacturer savings cards for anyone on Medicaid.
If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to California, see the cheapest GLP-1 in California guide.
51 GLP-1 clinical trials are recruiting in California, and a study supplies its own study medication. Every site is listed on GLP-1 clinical trials in California.
California Medicaid GLP-1 FAQ
Does Medi-Cal (California Medicaid) cover Wegovy for weight loss?
Does Medi-Cal (California Medicaid) cover Zepbound for weight loss?
Does Medi-Cal (California Medicaid) cover Ozempic or Mounjaro for diabetes?
What if Medi-Cal (California Medicaid) does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Checked August 24, 2026. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with California Medicaid, email hello@glpchart.com with the details and we will check it.